Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects.

P A Bacon1

  • 1Department of Rheumatology, Division of Immunity and Infection, Medical School, University of Birmingham, Edgbaston, UK. p.a.bacon@bham.ac.uk

Current Opinion in Rheumatology
|December 18, 2004
PubMed
Summary

Systemic vasculitis (SV) and connective tissue diseases (CTD) commonly cause endothelial cell dysfunction (ECD). This dysfunction may predict accelerated atherosclerosis and warrants further research for improved therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

The Use of Quantitative Thermography to Assess the Anti-inflammatory Dose Range for Fenclofenac.

Proceedings of the Royal Society of Medicine·2010
Same author

Intracellular calcium signalling patterns reflect the differentiation status of human T cells.

Clinical and experimental immunology·2008
Same author

Impaired endothelial function in systemic lupus erythematosus.

Lupus·2007
Same author

Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

Annals of the rheumatic diseases·2005
Same author

Assessing patient, carer and healthcare professional education provided by the Birmingham Arthritis Resource Centre (BARC).

Rheumatology (Oxford, England)·2004

Area of Science:

  • Vascular biology and immunology
  • Rheumatology and autoimmune diseases

Background:

  • The endothelium's role in inflammation is well-studied in atherosclerosis but less so in systemic vasculitis (SV).
  • Systemic vasculitis and connective tissue diseases (CTD) involve multi-organ damage, likely affecting the endothelium.
  • Endothelial function assessment is a valuable clinical research tool.

Purpose of the Study:

  • To review the application of endothelial function assessment in primary SV and CTD.
  • To highlight the significance of the endothelium in the pathophysiology of SV and CTD.

Main Methods:

  • Review of existing literature and clinical research on endothelial function in SV and CTD.
  • Utilizing various techniques to document endothelial cell dysfunction (ECD).

Related Experiment Videos

Main Results:

  • Diffuse endothelial cell dysfunction (ECD) is common in adult and childhood SV, as well as in CTD.
  • Mechanisms of ECD likely involve inflammatory cytokines like TNF.
  • Vasculitis may lead to diffuse ECD through mediators released into the bloodstream.

Conclusions:

  • Endothelial injury is a key factor in atherosclerosis and may initiate accelerated cardiovascular disease in CTD.
  • Similar endothelial dysfunction in primary SV suggests increased atherosclerosis risk.
  • Persistent ECD in Kawasaki syndrome correlates with coronary abnormalities.
  • Further research on endothelial function in SV is crucial for understanding clinical outcomes and developing targeted therapies.